| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Ikena Oncology (NASDAQ:IKNA) reported its Q4 earnings results on Tuesday, March 12, 2024 at 08:00 AM.
Here's what investors need to know about the announcement.
Ikena Oncology beat estimated earnings by 5.0%, reporting an EPS of $-0.41 versus an estimate of $-0.43.
Revenue was down $4.79 million from the same period last year.
Last quarter the company beat on EPS by $0.03 which was followed by a 10.0% increase in the share price the next day.
Here's a look at Ikena Oncology's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.43 | -0.47 | -0.47 | -0.48 |
| EPS Actual | -0.40 | -0.44 | -0.39 | -0.39 |
| Revenue Estimate | 2.55M | 3.08M | 4.61M | 6.02M |
| Revenue Actual | 1.19M | 2.00M | 5.31M | 5.45M |
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Ikena Oncology visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: IKNA
